Earnings NYSE Nasdaq 100 U.S. Tech Politics Science AI SEC Business Wall Street Energy Dow Jones Bitcoin (BTC) Dividend Investing NVIDIA (NVDA) Markets Economy S&P 500 China Donald Trump World Fed Crude Oil Tesla (TSLA) Money Inflation Gold Software U.K. Entertainment Health Apple (AAPL) Retail Wealth Amazon (AMZN) Taxes Europe Real Estate Elon Musk 3M (MMM) Natural Gas Retirement Microsoft (MSFT) Security Current Meta Platforms (META) Canada Options Truist Financial Corp (TFC) Boeing (BA) Jim Cramer Tax Hedge Funds Insurance Google Sports Live Manufacturing Cars Economics Pharmaceuticals Mining Airlines War Costco (COST) Ukraine Warren Buffett Japan Holidays Construction Silver York Finance Goldman Sachs (GS) Interest Rates New York BlackRock (BLK) Kamala Harris Walmart (WMT) OpenAI ChatGPT REITs Space Mortgage Internet JPMorgan (JPM) Aerospace Enterprise Ethereum (ETH) Intel (INTC) Walt Disney (DIS) GBP USD Netflix (NFLX) India Texas Morgan Stanley (MS) Australia IPOsMore +
Market Insider Market Insider
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Cryptocurrency
  • Forex
  • Tech
  • Politics
  • +

3 weeks Analyst Report: AMGEN Inc.Yahoo Finance

Analyst Report: AMGEN Inc..

Amgen (AMGN)

X       

19 hours Why Amgen (AMGN) is a Top Value Stock for the Long-TermZacks X       

5 days Amgen Sells Off: Keep Calm And Buy The DipSeeking Alpha X       

5 days Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on ItZacks X       

7 days 2 Reasons to Buy Amgen Stock, and 1 Reason to Be CautiousThe Motley Fool X       

1 week Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcareFXStreet X       

1 week Amgen Shrugs Off Bone Density Concerns Related to Obesity CandidateZacks X       

1 week Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript)Seeking Alpha X       

1 week Trade Tracker: Joe Terranova sells Amgen and buys XBIYouTube X       

1 week Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?Investor's Business Daily X       

1 week Amgen dismisses bone density concerns related to its new weight-loss drugInvesting.com X       

1 week Amgen sinks as Cantor flags issues with obesity drugYouTube X       

1 week Amgen stock falls as analysts mull over weight loss drug’s bone density dataCNBC X       

2 weeks Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity ShotInvestor's Business Daily X       

3 weeks Big Pharma’s Obesity Bonanza Faces New TestsThe Wall Street Journal X       

3 weeks Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha X       

3 weeks Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHCYahoo Finance X       

3 weeks Amgen Inc. (AMGN) Q3 2024 Earnings Call TranscriptSeeking Alpha X       

3 weeks Amgen Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X       

3 weeks Amgen (AMGN) Q3 2024 Earnings Call TranscriptThe Motley Fool X       

3 weeks Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily X       

3 weeks Amgen beats Q3 earnings estimates, raises full-year guidanceInvesting.com X       

4 weeks Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen.Investor's Business Daily X       

4 weeks First American Bank Has $4.18 Million Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

4 weeks Zacks Research Forecasts Amgen’s Q1 Earnings (NASDAQ:AMGN)MarketBeat X       

4 weeks Amgen Inc. Declares Quarterly Dividend of $2.25 (NASDAQ:AMGN)MarketBeat X       

4 weeks Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The ListSeeking Alpha X       

1 month Amgen Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks X       

1 month Allspring Global Investments Holdings LLC Sells 11,091 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

1 month Amgen (NASDAQ:AMGN) Stock Rating Reaffirmed by Cantor FitzgeraldMarketBeat X       

1 month Amgen Inc. (NASDAQ:AMGN) Shares Sold by Raleigh Capital Management Inc.MarketBeat X       

1 month Why Amgen (AMGN) Dipped More Than Broader Market TodayZacks X       

1 month Amgen (NASDAQ:AMGN) Price Target Raised to $383.00MarketBeat X       

1 month Penn Davis Mcfarland Inc. Raises Stake in Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

1 month Creative Planning Has $63.40 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

1 month Raymond James & Associates Sells 71,201 Shares of Amgen Inc. (NASDAQ:AMGN)MarketBeat X       

More news +
Home | Contact
  • X

© 2024 Market Insider